Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer

The therapeutic algorithm of lung cancer has recently been revolutionized by the emergence of immune checkpoint inhibitors. However, an objective and durable response rate remains low with those recent therapies and some patients even experience severe adverse events. Prognostic and predictive bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Pabst, Lucile, Lopes, Sébastien, Bertrand, Basil, Creusot, Quentin, Kotovskaya, Maria, Pencreach, Erwan, Beau-Faller, Michèle, Mascaux, Céline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145126/
https://www.ncbi.nlm.nih.gov/pubmed/37108738
http://dx.doi.org/10.3390/ijms24087577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145126/
https://www.ncbi.nlm.nih.gov/pubmed/37108738
http://dx.doi.org/10.3390/ijms24087577

Ejemplares similares